Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Operating Leases: 2019-2023

Historic Operating Leases for Solid Biosciences (SLDB) over the last 5 years, with Dec 2023 value amounting to $22.7 million.

  • Solid Biosciences' Operating Leases fell 6.67% to $21.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $21.6 million, marking a year-over-year decrease of 6.67%. This contributed to the annual value of $22.7 million for FY2023, which is 6.47% down from last year.
  • Solid Biosciences' Operating Leases amounted to $22.7 million in FY2023, which was down 6.47% from $24.3 million recorded in FY2022.
  • Solid Biosciences' Operating Leases' 5-year high stood at $24.3 million during FY2022, with a 5-year trough of $275,000 in FY2021.
  • Its 3-year average for Operating Leases is $15.8 million, with a median of $22.7 million in 2023.
  • In the last 5 years, Solid Biosciences' Operating Leases crashed by 88.63% in 2021 and then soared by 8,728.73% in 2022.
  • Solid Biosciences' Operating Leases (Yearly) stood at $4.4 million in 2019, then slumped by 45.20% to $2.4 million in 2020, then crashed by 88.63% to $275,000 in 2021, then spiked by 8,728.73% to $24.3 million in 2022, then decreased by 6.47% to $22.7 million in 2023.